人工肺市場：製品タイプ、技術、患者年齢層、コンポーネント、用途、エンドユーザー別-2025-2030年世界予測

人工肺市場は、2023年に70億2,000万米ドルと評価され、2024年には76億3,000万米ドルに達すると予測され、CAGR 8.76％で成長し、2030年には126億5,000万米ドルに達すると予測されています。

人工肺市場には、主に呼吸不全や疾患を管理するために、生体肺のガス交換機能を複製またはサポートする機器や技術が含まれます。慢性呼吸器疾患の世界の流行に伴い、人工肺システムの需要はますます重要になってきています。集中治療室での一時的な呼吸補助から、肺の利用可能性が限られている移植シナリオでの代替まで、用途は多岐にわたる。自動車、医療研究、ヘルスケア部門が最終用途領域として機能し、材料や生体適合技術の進歩によりバイオテクノロジー企業からの関心も高まっています。慢性閉塞性肺疾患（COPD）や急性呼吸窮迫症候群（ARDS）の増加、世界の高齢化が市場促進要因となっています。携帯型人工肺や埋め込み型人工肺の開発と並んで、デバイスの寿命向上につながる生体材料の革新は、有利な機会を提供します。しかし、高い製造コスト、厳しい規制要件、潜在的な生体適合性の問題などの課題は、市場の成長を阻害する可能性があります。ビジネスチャンスを生かすためには、企業はナノテクノロジーや生体適合性ポリマーの研究を通じて、デバイスの効率と人間工学を高めることに注力すべきです。また、機械的支持と生物学的組織工学を組み合わせたハイブリッド・システムの探求にも可能性があります。市場の性質は競合が激しく、かつ技術革新の機が熟しており、主要プレーヤーは課題や規制のハードルを乗り越えるために研究開発に投資しています。私はアナリストとして、イノベーションを促進し、規制遵守を促進するために、医療研究機関との共同研究や官民パートナーシップの模索に投資することを推奨します。規制が緩やかな新興市場に進出すれば、参入が容易になり、市場浸透が進む可能性があります。個別化された人工肺ソリューションの開発など、患者中心のアプローチへの重点開拓を強化することで、採用が促進され、患者の転帰が改善され、市場拡大が促進される可能性もあります。

市場力学：急速に進化する人工肺市場の主要市場インサイトを公開

人工肺市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人工肺需要を牽引する呼吸器疾患および肺移植の増加
  • 人工肺のデザインと機能性における技術的進歩が業界の成長を促進
  • 人工肺システムの研究開発への投資と資金提供の増加
  • 高齢者人口の増加と慢性肺疾患の増加が市場の需要を高める
• 市場抑制要因
  • 人工肺デバイスの操作やメンテナンスに必要な熟練した専門家や専門知識が限られていること
  • 人工肺材料の生体適合性と長期耐久性に関する懸念が採用率に影響
• 市場機会
  • 呼吸支援システムを最適化するためのAI駆動型人工肺の開発
  • 長寿命で耐久性のある人工肺を作るための再生医療アプローチ
  • リアルタイムのモニタリングとメンテナンスのための人工肺とモノのインターネット（iot）の統合
• 市場の課題
  • ヘルスケア環境における人工肺の普及を阻む技術的限界と信頼性への懸念
  • 人工肺の研究開発と展開に影響を与える倫理的配慮と社会的認知の問題

ポーターの5つの力：人工肺市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：人工肺市場における外部からの影響の把握

外部マクロ環境要因は、人工肺市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析人工肺市場における競合情勢の把握

人工肺市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス人工肺市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、人工肺市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨人工肺市場における成功への道筋を描く

人工肺市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 呼吸器疾患と肺移植の増加により人工肺の需要が増加
    • 人工肺のデザインと機能における技術的進歩が業界の成長を牽引
    • 人工肺システムの研究開発への投資と資金の増加
    • 高齢者人口の増加と慢性肺疾患の発症率の上昇により、市場の需要が高まっています。
  • 抑制要因
    • 人工肺デバイスの操作と保守に必要な熟練した専門家と専門知識が限られている
    • 人工肺材料の生体適合性と長期耐久性に関する懸念が採用率に影響
  • 機会
    • 呼吸補助システムを最適化するAI駆動型人工肺の開発
    • 長持ちする耐久性のある人工肺を作るための再生医療アプローチ
    • リアルタイムの監視とメンテナンスのための人工肺とモノのインターネット（IoT）の統合
  • 課題
    • 技術的な限界と信頼性の懸念により、ヘルスケア現場での人工肺の普及が遅れている
    • 人工肺の研究開発と導入に影響を与える倫理的配慮と世論の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 人工肺市場：製品タイプ別

• 体外式膜型人工肺（ECMO）
• 肺内ガス交換
• 体外人工肺

第7章 人工肺市場：技術別

• 酸素化技術
• ポンプ技術
• センサーとモニター

第8章 人工肺市場患者の年齢層別

• 成人用
• 高齢者
• 新生児
• 小児科

第9章 人工肺市場：コンポーネント別

• カニューレ
• コントローラー
• 膜型人工肺
• パンプス

第10章 人工肺市場：用途別

• 急性呼吸窮迫症候群（ARDS）
• 心肺バイパス
• 慢性閉塞性肺疾患（COPD）

第11章 人工肺市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院

第12章 南北アメリカの人工肺市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の人工肺市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの人工肺市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Abbott Laboratories
• 2. ALung Technologies, Inc.
• 3. B. Braun Melsungen AG
• 4. Baxter International Inc.
• 5. Breethe, Inc.
• 6. CardiacAssist, Inc.
• 7. Cleveland Clinic
• 8. Dragerwerk AG & Co. KGaA
• 9. Fresenius Medical Care AG & Co. KGaA
• 10. Getinge AB
• 11. Hemovent GmbH
• 12. Maquet Holding B.V. & Co. KG
• 13. McGowan Institute for Regenerative Medicine
• 14. Medtronic plc
• 15. Novalung GmbH
• 16. Organ Care System (OCS)
• 17. Respiratory Assist
• 18. Terumo Corporation
• 19. Xenios AG
• 20. Xenios USA, Inc

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL LUNG MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL LUNG MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARTIFICIAL LUNG MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL LUNG MARKET DYNAMICS
• TABLE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO), BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY INTRAPULMONARY GAS EXCHANGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PARACORPOREAL ARTIFICIAL LUNGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY OXYGENATOR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMP TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY SENSORS AND MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY NEONATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CONTROLLERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 55. CANADA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 56. CANADA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. CANADA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. CHINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 87. CHINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. CHINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. CHINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 93. INDIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 94. INDIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. INDIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. ITALY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 196. ITALY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 197. ITALY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. ITALY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. POLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 220. POLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 221. POLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. POLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. QATAR ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 226. QATAR ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 227. QATAR ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. QATAR ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 283. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 284. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023

The Artificial Lung Market was valued at USD 7.02 billion in 2023, expected to reach USD 7.63 billion in 2024, and is projected to grow at a CAGR of 8.76%, to USD 12.65 billion by 2030.

The artificial lung market encompasses devices and technologies that replicate or support the gas exchange functions of biological lungs, primarily to manage respiratory failures or diseases. With a growing prevalence of chronic respiratory diseases worldwide, the demand for artificial lung systems is becoming increasingly vital. Applications span from temporary respiratory support in intensive care units to alternatives in transplant scenarios, where lung availability is limited. Automotive, medical research, and healthcare sectors serve as end-use domains, with an increasing interest from biotechnology firms due to advancements in materials and biocompatible technologies. A significant growth driver is the rise in chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) cases, as well as the global aging population, which boosts market potential. Innovations in biomaterials leading to improved device lifespan, alongside the development of portable and implantable artificial lungs, offer lucrative opportunities. However, challenges like high manufacturing costs, stringent regulatory requirements, and potential biocompatibility issues may impede market growth. To capitalize on opportunities, companies should focus on enhancing device efficiency and ergonomics through research into nanotechnology and biocompatible polymers. There is also potential in exploring hybrid systems that combine mechanical support with biological tissue engineering. The nature of the market is both competitive and ripe for innovation, dominated by key players investing in R&D to outpace challenges and regulatory hurdles. As an analyst, I recommend investing in collaborations with medical research institutions and exploring public-private partnerships to foster innovation and facilitate regulatory compliance. Expanding into emerging markets, which may have less stringent regulations, could offer easier entry points and further market penetration. Enhanced focus on patient-centric approaches, such as developing personalized artificial lung solutions, could also bolster adoption and improve patient outcomes, driving market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Lung Market

The Artificial Lung Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
  • Technological advancements in artificial lung design and functionality driving industry growth
  • Growing investment and funding in research and development of artificial lung systems
  • Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
• Market Restraints
  • Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
  • Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
• Market Opportunities
  • Development of ai-driven artificial lungs to optimize respiratory support systems
  • Regenerative medicine approaches for creating long-lasting and durable artificial lungs
  • Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
• Market Challenges
  • Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
  • Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Lung Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Lung Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Lung Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Lung Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Lung Market

A detailed market share analysis in the Artificial Lung Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Lung Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Lung Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Lung Market

A strategic analysis of the Artificial Lung Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Lung Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALung Technologies, Inc., B. Braun Melsungen AG, Baxter International Inc., Breethe, Inc., CardiacAssist, Inc., Cleveland Clinic, Dragerwerk AG & Co. KGaA, Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, Maquet Holding B.V. & Co. KG, McGowan Institute for Regenerative Medicine, Medtronic plc, Novalung GmbH, Organ Care System (OCS), Respiratory Assist, Terumo Corporation, Xenios AG, and Xenios USA, Inc.

Market Segmentation & Coverage

This research report categorizes the Artificial Lung Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Extracorporeal Membrane Oxygenation (ECMO), Intrapulmonary Gas Exchange, and Paracorporeal Artificial Lungs.
• Based on Technology, market is studied across Oxygenator Technology, Pump Technology, and Sensors and Monitors.
• Based on Patient Age Group, market is studied across Adult, Geriatric, Neonates, and Pediatric.
• Based on Component, market is studied across Cannulas, Controllers, Membrane Oxygenators, and Pumps.
• Based on Application, market is studied across Acute Respiratory Distress Syndrome (ARDS), Cardiopulmonary Bypass, and Chronic Obstructive Pulmonary Disease (COPD).
• Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
    • 5.1.1.2. Technological advancements in artificial lung design and functionality driving industry growth
    • 5.1.1.3. Growing investment and funding in research and development of artificial lung systems
    • 5.1.1.4. Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
    • 5.1.2.2. Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of ai-driven artificial lungs to optimize respiratory support systems
    • 5.1.3.2. Regenerative medicine approaches for creating long-lasting and durable artificial lungs
    • 5.1.3.3. Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
  • 5.1.4. Challenges
    • 5.1.4.1. Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
    • 5.1.4.2. Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Lung Market, by Product Type

• 6.1. Introduction
• 6.2. Extracorporeal Membrane Oxygenation (ECMO)
• 6.3. Intrapulmonary Gas Exchange
• 6.4. Paracorporeal Artificial Lungs

7. Artificial Lung Market, by Technology

• 7.1. Introduction
• 7.2. Oxygenator Technology
• 7.3. Pump Technology
• 7.4. Sensors and Monitors

8. Artificial Lung Market, by Patient Age Group

• 8.1. Introduction
• 8.2. Adult
• 8.3. Geriatric
• 8.4. Neonates
• 8.5. Pediatric

9. Artificial Lung Market, by Component

• 9.1. Introduction
• 9.2. Cannulas
• 9.3. Controllers
• 9.4. Membrane Oxygenators
• 9.5. Pumps

10. Artificial Lung Market, by Application

• 10.1. Introduction
• 10.2. Acute Respiratory Distress Syndrome (ARDS)
• 10.3. Cardiopulmonary Bypass
• 10.4. Chronic Obstructive Pulmonary Disease (COPD)

11. Artificial Lung Market, by End-User

• 11.1. Introduction
• 11.2. Ambulatory Surgical Centers
• 11.3. Clinics
• 11.4. Hospitals

12. Americas Artificial Lung Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Artificial Lung Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Artificial Lung Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ALung Technologies, Inc.
• 3. B. Braun Melsungen AG
• 4. Baxter International Inc.
• 5. Breethe, Inc.
• 6. CardiacAssist, Inc.
• 7. Cleveland Clinic
• 8. Dragerwerk AG & Co. KGaA
• 9. Fresenius Medical Care AG & Co. KGaA
• 10. Getinge AB
• 11. Hemovent GmbH
• 12. Maquet Holding B.V. & Co. KG
• 13. McGowan Institute for Regenerative Medicine
• 14. Medtronic plc
• 15. Novalung GmbH
• 16. Organ Care System (OCS)
• 17. Respiratory Assist
• 18. Terumo Corporation
• 19. Xenios AG
• 20. Xenios USA, Inc